Large‐scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma

• Published in: Clinical and translational allergy Vol. 11; no. 10; pp. e12091 - n/a
• Main Authors: Suzuki, Masaru, Cole, John J., Konno, Satoshi, Makita, Hironi, Kimura, Hiroki, Nishimura, Masaharu, Maciewicz, Rose A.
• Format: Journal Article
• Language: English
• Published: England John Wiley & Sons, Inc 01.12.2021; John Wiley and Sons Inc; Wiley
• Subjects: asma severa; Asthma; asthme sévère; Biology; Body mass index; BPCO; Bronchodilators; Cardiovascular disease; Chronic illnesses; Chronic obstructive pulmonary disease; COPD; Datasets; endotipos; endotypen; endotypes; EPOC; exosomas; exosome; exosomen; exosomes; Gene expression; Hay fever; Hospitals; Original; Patients; Plasma; Proteins; proteomic; Proteomics; proteómica; protéomique; Respiratory diseases; Rhinitis; schweres Asthma; severe asthma; エクソソーム; エンドタイプ; プロテオミクス; 重症喘息; プロテオミクス; proteomics; BPCO; endotipos; protéomique; asthme sévère; proteomic; エンドタイプ; exosomen; asma severa; endotypes; エクソソーム; exosomas; proteómica; endotypen; exosomes; schweres Asthma; severe asthma; 重症喘息; exosome; COPD; EPOC
• ISSN: 2045-7022; 2045-7022
• DOI: 10.1002/clt2.12091

Background Chronic airway diseases including chronic obstructive pulmonary disease (COPD) and asthma are heterogenous in nature and endotypes within are underpinned by complex biology. This study aimed to investigate the utility of proteomic profiling of plasma combined with bioinformatic mining, and to define molecular endotypes and expand our knowledge of the underlying biology in chronic respiratory diseases. Methods The plasma proteome was evaluated using an aptamer‐based affinity proteomics platform (SOMAscan®), representing 1238 proteins in 34 subjects with stable COPD and 51 subjects with stable but severe asthma. For each disease, we evaluated a range of clinical/demographic characteristics including bronchodilator reversibility, blood eosinophilia levels, and smoking history. We applied modified bioinformatic approaches used in the evaluation of RNA transcriptomics. Results Subjects with COPD and severe asthma were distinguished from each other by 365 different protein abundancies, with differential pathway networks and upstream modulators. Furthermore, molecular endotypes within each disease could be defined. The protein groups that defined these endotypes had both known and novel biology including groups significantly enriched in exosomal markers derived from immune/inflammatory cells. Finally, we observed associations to clinical characteristics that previously have been under‐explored. Conclusion This investigational study evaluating the plasma proteome in clinically‐phenotyped subjects with chronic airway diseases provides support that such a method can be used to define molecular endotypes and pathobiological mechanisms that underpins these endotypes. It provided new concepts about the complexity of molecular pathways that define these diseases. In the longer term, such information will help to refine treatment options for defined groups.